Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.

Kreitman RJ, Wilson WH, Bergeron K, Raggio M, Stetler-Stevenson M, FitzGerald DJ, Pastan I.

N Engl J Med. 2001 Jul 26;345(4):241-7.

2.

Immunobiological treatments of hairy-cell leukaemia.

Kreitman RJ, Pastan I.

Best Pract Res Clin Haematol. 2003 Mar;16(1):117-33. Review.

PMID:
12670470
3.

The disease with hope: hairy cell leukemia.

Becker SE.

Clin J Oncol Nurs. 2007 Oct;11(5):731-5. Review.

PMID:
17962181
4.

Immunoconjugates in the management of hairy cell leukemia.

Kreitman RJ, Pastan I.

Best Pract Res Clin Haematol. 2015 Dec;28(4):236-45. doi: 10.1016/j.beha.2015.09.003. Epub 2015 Oct 9. Review.

5.

Technology evaluation: BL22, NCI.

Barth S.

Curr Opin Mol Ther. 2002 Feb;4(1):72-5. Review.

PMID:
11883697
6.

Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia.

Kreitman RJ, Arons E, Stetler-Stevenson M, Fitzgerald DJ, Wilson WH, Pastan I.

Leuk Lymphoma. 2011 Jun;52 Suppl 2:82-6. doi: 10.3109/10428194.2011.565843. Review.

PMID:
21599609
7.

Cladribine in hairy cell leukemia.

Belani R, Saven A.

Hematol Oncol Clin North Am. 2006 Oct;20(5):1109-23. Review.

PMID:
16990111
8.

Approach to the patient after relapse of hairy cell leukemia.

Kreitman RJ, Fitzgerald DJ, Pastan I.

Leuk Lymphoma. 2009 Oct;50 Suppl 1:32-7. doi: 10.3109/10428190903142216. Review.

PMID:
19814696
9.

BL22 and lymphoid malignancies.

Kreitman RJ, Pastan I.

Best Pract Res Clin Haematol. 2006;19(4):685-99. Review.

PMID:
16997177
10.

Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Kreitman RJ.

BioDrugs. 2009;23(1):1-13. doi: 10.2165/00063030-200923010-00001. Review.

11.
12.

Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.

Huynh E, Sigal D, Saven A.

Leuk Lymphoma. 2009 Oct;50 Suppl 1:12-7. doi: 10.3109/10428190903142083. Review.

PMID:
19814692
13.

Toxin-labeled monoclonal antibodies.

Kreitman RJ.

Curr Pharm Biotechnol. 2001 Dec;2(4):313-25. Review.

PMID:
11762413
14.

Immunotoxins in the treatment of refractory hairy cell leukemia.

Kreitman RJ, Pastan I.

Hematol Oncol Clin North Am. 2006 Oct;20(5):1137-51, viii. Review.

PMID:
16990113
15.

2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up.

Gidron A, Tallman MS.

Leuk Lymphoma. 2006 Nov;47(11):2301-7. Review.

PMID:
17107901
16.

Immunotoxins in the treatment of hematologic malignancies.

Kreitman RJ, Pastan I.

Curr Drug Targets. 2006 Oct;7(10):1301-11. Review.

PMID:
17073592
17.

Management of hairy cell leukemia variant.

Robak T.

Leuk Lymphoma. 2011 Jun;52 Suppl 2:53-6. doi: 10.3109/10428194.2011.566392. Review.

PMID:
21599606
18.

[Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].

Rucińska M, Machaczka M, Załuska A, Skotnicki AB.

Przegl Lek. 1998;55(7-8):400-6. Review. Polish.

PMID:
10021885
19.

Cladribine in the treatment of hairy-cell leukaemia.

Goodman GR, Beutler E, Saven A.

Best Pract Res Clin Haematol. 2003 Mar;16(1):101-16. Review.

PMID:
12670469
20.

Recombinant immunotoxins for the treatment of haematological malignancies.

Kreitman RJ.

Expert Opin Biol Ther. 2004 Jul;4(7):1115-28. Review.

PMID:
15268678

Supplemental Content

Support Center